Last10K.com

Ampio Pharmaceuticals, Inc. (AMPE) SEC Filing 10-K Annual report for the fiscal year ending Thursday, December 31, 2020

Ampio Pharmaceuticals, Inc.

CIK: 1411906 Ticker: AMPE
Document And Entity Information - USD ($)
$ in Millions
12 Months Ended
Dec. 31, 2020
Feb. 16, 2021
Jun. 30, 2020
Document And Entity Information [Abstract]   
Document Type10-K  
Document Annual Reporttrue  
Document Period End DateDec. 31, 2020  
Document Transition Reportfalse  
Entity File Number001-35182  
Entity Registrant NameAMPIO PHARMACEUTICALS, INC.  
Entity Incorporation, State or Country CodeDE  
Entity Tax Identification Number26-0179592  
Entity Address, Address Line One373 Inverness Parkway  
Entity Address, Address Line TwoSuite 200  
Entity Address, City or TownEnglewood  
Entity Address, State or ProvinceCO  
Entity Address, Postal Zip Code80112  
City Area Code720  
Local Phone Number437-6500  
Title of 12(b) SecurityCommon Stock, par value $0.0001 per share  
Trading SymbolAMPE  
Security Exchange NameNYSEAMER  
Entity Well-known Seasoned IssuerNo  
Entity Voluntary FilersNo  
Entity Current Reporting StatusYes  
Entity Interactive Data CurrentYes  
Entity Filer CategoryNon-accelerated Filer  
Entity Small Businesstrue  
Entity Emerging Growth Companyfalse  
Entity Shell Companyfalse  
Entity Public Float  $ 106.2
Entity Common Stock, Shares Outstanding 195,629,128 
Entity Central Index Key0001411906  
Current Fiscal Year End Date--12-31  
Document Fiscal Year Focus2020  
Document Fiscal Period FocusFY  
Amendment Flagfalse  

View differences made from one year to another to evaluate Ampio Pharmaceuticals, Inc.'s financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 10-K Annual Report to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Ampio Pharmaceuticals, Inc..

Continue

Assess how Ampio Pharmaceuticals, Inc.'s management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Ampio Pharmaceuticals, Inc.'s Definitive Proxy Statement (Form DEF 14A) filed after their 2021 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors

Continue

Tools

Rating

Learn More
Bullish Bearish Neutral
Filter by Sentiment:
All
Positive
Negative
Filter by Category:
All
Financial
Legal
Other
Filter by Subcategory:
All
Shares
Expense
Other
Inside Ampio Pharmaceuticals, Inc.'s 10-K Annual Report:

Financial Statements, Disclosures and Schedules

Inside this 10-K Annual Report

Document And Entity Information
Condensed Balance Sheets
Condensed Balance Sheets (Parenthetical)
Condensed Statements Of Cash Flows
Condensed Statements Of Operations
Condensed Statements Of Stockholders' Equity
Accounts Payable And Accrued Expenses
Accounts Payable And Accrued Expenses (Detail)
Accounts Payable And Accrued Expenses (Tables)
Basis Of Presentation
Commitments And Contingencies
Commitments And Contingencies (Tables)
Commitments And Contingencies - Additional Information (Detail)
Commitments And Contingencies - Employment Agreements (Detail)
Commitments And Contingencies - Lease Expense (Detail)
Commitments And Contingencies - Summary Of Commitments And Contingencies (Detail)
Commitments And Contingencies - Summary Of Reconciliation Of Company's Undiscounted Payments For Facility Lease And Carrying Amount Of Lease Liability (Detail)
Common Stock
Common Stock (Common Stock Issued For Services) (Detail)
Common Stock (Public Offering Narrative) (Detail)
Common Stock (Sales Agreement) (Detail)
Common Stock (Summarizes The Company's Remaining Authorized Shares Available - (Detail)
Common Stock (Summary Of Company's Sales Under The Equity Distribution Agreement) (Detail)
Common Stock (Tables)
Earnings Per Share
Earnings Per Share (Detail)
Earnings Per Share (Tables)
Earnings Per Share - Narrative (Detail)
Employee Benefit Plan
Equity Instruments
Equity Instruments (Tables)
Equity Instruments - Activity Of Plan (Detail)
Equity Instruments - Assumptions Used In Computing Fair Value Of All Options Granted (Detail)
Equity Instruments - Stock Option Activity (Detail)
Equity Instruments - Summary Of Stock Options Outstanding And Exercisable (Detail)
Equity Instruments - Summary Of Stock-Based Compensation Expense (Detail)
Fair Value Considerations
Fair Value Considerations (Tables)
Fair Value Considerations - Financial Assets And Liabilities (Detail)
Fair Value Considerations - Sets Forth A Reconciliation Of Changes (Detail)
Fixed Assets
Fixed Assets (Detail)
Fixed Assets (Tables)
Fixed Assets - Depreciation Expenses (Detail)
Going Concern
Going Concern (Detail)
Income Taxes
Income Taxes (Tables)
Income Taxes - Additional Information (Detail)
Income Taxes - Deferred Tax Assets And Liabilities (Detail)
Income Taxes - Reconciliation Of Effective Tax Rate (Detail)
Litigation
Paycheck Protection Program
Paycheck Protection Program - Additional Information (Detail)
Prepaid Expenses And Other
Prepaid Expenses And Other (Detail)
Prepaid Expenses And Other (Tables)
Subsequent Events
Subsequent Events (Details)
Summary Of Significant Accounting Policies
Summary Of Significant Accounting Policies (Policies)
Summary Of Significant Accounting Policies - Impairment Of Long-Lived Assets (Detail)
Warrants
Warrants (Tables)
Warrants - (Detail)
Warrants - Assumptions For Warrants Issued (Detail)
Warrants - Warrants Activity (Detail)
Warrants - Warrants Activity Classified As Equity And Liability (Detail)
Ticker: AMPE
CIK: 1411906
Form Type: 10-K Annual Report
Accession Number: 0001558370-21-002314
Submitted to the SEC: Wed Mar 03 2021 4:11:50 PM EST
Accepted by the SEC: Wed Mar 03 2021
Period: Thursday, December 31, 2020
Industry: Pharmaceutical Preparations

External Resources:
Stock Quote
Social Media

Bookmark the Permalink:
https://last10k.com/sec-filings/ampe/0001558370-21-002314.htm